Development of semagacestat (LY450139), a functional γ-secretase inhibitor, for the treatment of Alzheimer's disease
Year: 2009
Type: review
Institution: Eli Lilly (United States)
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: closed
Funder: Eli Lilly and Company
OpenAlex ID: W2065706231
